Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLTC | Q00610 | 14/20 | 0.79 |
| ▸ | CA12 | O43570 | 2/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CA9 | Q16790 | 2/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | AHR | P35869 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | PARG | Q86W56 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14636234 | 0.90 | CLTC (0.78) | CLTCCA12CA1CA2CA9 | |
| SCHEMBL14636004 | 0.89 | CLTC (0.79) | CLTCCA12CA1CA2CA9 | |
| SCHEMBL14636859 | 0.89 | CLTC (0.77) | CLTCCA12CA1CA2CA9 | |
| SCHEMBL14636718 | 0.88 | CLTC (0.78) | CLTCCA12CA1CA2CA9 | |
| SCHEMBL14636868 | 0.88 | CLTC (0.78) | CLTCCA12CA1CA2CA9 | |
| SCHEMBL29483205 | 0.87 | CLTC (0.98) | CLTCCA12CA1CA2CA9 | |
| SCHEMBL14636558 | 0.85 | CLTC (0.79) | CLTCCA12CA1CA2CA9 | |
| SCHEMBL14635611 | 0.84 | CA12 (0.69) | CLTCCA12CA1CA2CA9 | |
| SCHEMBL14636204 | 0.84 | CLTC (0.72) | CLTCCA12CA1CA2CA9 | |
| SCHEMBL14636506 | 0.83 | CLTC (0.67) | CLTCCA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023239903-A1 | COMPOSITIONS AND METHODS FOR PREVENTING RETENTION OF PSMA-TARGETED THERAPY | CASE WESTERN RESERVE UNIVERSITY (US) | 2023-12-14 | — | — | WO | claimed |
| WO-2023239903-A1 | COMPOSITIONS AND METHODS FOR PREVENTING RETENTION OF PSMA-TARGETED THERAPY | CASE WESTERN RESERVE UNIVERSITY (US) | 2023-12-14 | — | — | WO | disclosed |
| WO-2013010218-A9 | INHIBITION OF CLATHRIN | FREIE UNIVERSITÄT BERLIN (DE) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013010218-A9 | INHIBITION OF CLATHRIN | FREIE UNIVERSITÄT BERLIN (DE) | 2013-03-28 | — | — | WO | disclosed |
| WO-2013010218-A1 | INHIBITION OF CLATHRIN | FREIE UNIVERSITÄT BERLIN (DE) | 2013-01-24 | — | — | WO | disclosed |
| WO-2013010218-A1 | INHIBITION OF CLATHRIN | FREIE UNIVERSITÄT BERLIN (DE) | 2013-01-24 | — | — | WO | disclosed |